Updated phase 1 data indicate that a single infusion of Caribou Biosciences' CB-011, an allogeneic anti-BCMA CAR-T cell therapy, can induce deep and...

Some of the best links we picked up around the internet

Some of the best links we picked up around the internet

Some of the best links we picked up around the internet

Caribou Biosciences reported last week that its off-the-shelf, CRISPR-edited anti-CD19 CAR-T, vispa-cel (formerly CB-010), achieved response rates and...

Some of the best links we picked up around the internet

Some of the best links we picked up around the internet

Some of the best links we picked up around the internet